2020 IPO

Relay Therapeutics Stock

Analyze the movement of proteins inside human cells

Sign up today and learn more about Relay Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Relay Therapeutics Stock

Relay Therapeutics was founded on the premise that putting protein motion at the heart of drug discovery can dramatically expand therapeutic possibilities.

Funding History

September 2016$57.0M
December 2017$63.0M
December 2018$400M


President & CEO

Sanjiv Patel

Chief Scientific Officer and Co-Founder

Mark Murcko

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: